TITAN PHARMACEUTICALS INC (TTNP)
Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. The company was founded by Louis R. Bucalo on February 7, 1992 and is headquartered in South San Francisco, CA.
Address
400 OYSTER POINT BLVD
SAN FRANCISCO, CA 94080
Founded
1992
Number of Employees
4
Website
http://www.titanpharm.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)